Figure 1
Figure 1. Current durations of CR or PR in relapsed AL patients treated with bortezomib, at data cutoff for this report.

Current durations of CR or PR in relapsed AL patients treated with bortezomib, at data cutoff for this report.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal